Stock Info Nets

Independent Financial Information Made Easy

Our AI creates

The Best Stock Graphs and Charts

Youtube Subscribe Blog GamificArt

The development of Artificial Intelligence (AI) is modifying the way investments are evaluated. We programmed an artificial intelligence (A.I.) to summarize the whole internet. Whether you’re trying to make money investing online, making financial decisions or just getting informed about Wall Street, this page is a way to get informed without reading hundred of pages. Our stock market summary graphs are produced using machine learning, an unbiased view to capture what internet is saying. Usually, the AI reads several hundred pages and summarize it to a short text and several charts.

General Description

Cognition Therapeutics

Youtube Subscribe

...

Ticker: CGTX

Sector: Biotechnology

Cognition Therapeutics, Inc. engages in the discovery and development of small molecule therapeutics. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to.
...
...
Extended Summary

Cognition Therapeutics

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex for the treatment of Alzheimer's disease. The company is also developing COG0201 SHINE, a randomized double-blind and placebo-controlled for mild-to-moderate AD and is in phase II clinical trial. Its product pipeline also includes CT2168 for Synucleinopathies; and CT2074 for dry age-related macular degeneration. The company was incorporated in 2007 and is headquartered in Purchase, New York.

Related Results

...
February 26, 2024 7:15 (London Time)

Cognition Therapeutics

Cognition Therapeutics is a clinical stage neuroscience company that operates in the healthcare and pharmaceutical industry. The leading companies w…
Sector: Biotechnology
Ticker: CGTX
Sentiment: -0.0772
MarketCap: 64,243,728.0
High: 2.05 Low: 1.9

Open: 1.99 Close: 2.0 Change: 0.01

Read more →
...
May 13, 2023 23:50 (London Time)

Cognition Therapeutics

Cognition Therapeutics stock opened at $1.07 on Friday and has a 52-week high of $6.27. R. Riley raised their Q2 2023 earnings per share estimates f…
Sector: Biotechnology
Ticker: CGTX
Sentiment: -0.2732
MarketCap: 45,672,480.0
High: 1.63 Low: 1.55

Open: 1.57 Close: 1.6 Change: 0.03

Read more →
Search
Happening Now
Categories